KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Total Debt: 2009-2025

Historic Total Debt for Ionis Pharmaceuticals (IONS) over the last 14 years, with Sep 2025 value amounting to $630.9 million.

  • Ionis Pharmaceuticals' Total Debt rose 1318.83% to $630.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $630.9 million, marking a year-over-year increase of 1318.83%. This contributed to the annual value of $51.9 million for FY2024, which is 39.74% down from last year.
  • Latest data reveals that Ionis Pharmaceuticals reported Total Debt of $630.9 million as of Q3 2025, which was up 0.13% from $630.1 million recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Total Debt ranged from a high of $630.9 million in Q3 2025 and a low of $8.8 million during Q1 2023.
  • Over the past 3 years, Ionis Pharmaceuticals' median Total Debt value was $48.2 million (recorded in 2024), while the average stood at $192.6 million.
  • In the last 5 years, Ionis Pharmaceuticals' Total Debt plummeted by 86.16% in 2023 and then spiked by 1,318.83% in 2025.
  • Over the past 5 years, Ionis Pharmaceuticals' Total Debt (Quarterly) stood at $63.2 million in 2021, then slumped by 74.74% to $16.0 million in 2022, then skyrocketed by 439.46% to $86.2 million in 2023, then plummeted by 39.74% to $51.9 million in 2024, then soared by 1,318.83% to $630.9 million in 2025.
  • Its Total Debt stands at $630.9 million for Q3 2025, versus $630.1 million for Q2 2025 and $51.9 million for Q4 2024.